PHVS
PHVS
NASDAQ · Pharmaceuticals

Pharvaris Nv

$32.80
-0.61 (-1.83%)
As of Jun 21, 10:06 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -31.7% upside
Low Target $12.72
Average Target $22.40
High Target $29.92
Current Price $32.80
Current
$32.80
Target
$22.40
$12.72 $22.40 avg $29.92
Scenario Analysis
Bear Case
$12.72
-61.2%
Low target
Base Case
$22.40
-31.7%
Avg target
Bull Case
$29.92
+-8.8%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$34.41
-4.7% from high
52-Week Low
$16.00
+105.0% from low
Target vs 52W High
$22.40
-34.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%